What is the recommended treatment for scabies?

Scabies Treatment

Topical permethrin 5% cream applied to the entire body from the neck down for 8–14 hours is the first-line treatment for scabies, with oral ivermectin 200 µg/kg on days 0 and 14 as an equally effective alternative. 1, 2

First-Line Treatment Options

Topical Permethrin 5%

• Apply permethrin 5% cream to the entire body surface from the neck down and wash off after 8–14 hours; this is the preferred regimen because it is more effective, safer, and less expensive than oral alternatives. 1, 2
• In infants and elderly patients, also treat the scalp, hairline, neck, temples, and forehead. 2
• Permethrin is safe during pregnancy and lactation. 2
• A repeat application after 7–10 days may be needed if symptoms persist beyond 2 weeks with documented live mites. 2

Important caveat: A 2024 randomized controlled trial from the British Journal of Dermatology found only a 27% cure rate with permethrin versus 87% with benzyl benzoate 25%, suggesting emerging resistance in some populations. 3 However, CDC guidelines still recommend permethrin as first-line based on its established safety profile and cost-effectiveness. 1, 2

Oral Ivermectin

• Give ivermectin 200 µg/kg orally on day 0 and repeat on day 14; the second dose is mandatory because ivermectin has limited ovicidal activity and cannot eradicate eggs present at initial treatment. 1, 2
• Administer with food to enhance bioavailability and epidermal penetration. 1, 2
• Do not use in children weighing less than 15 kg due to neurotoxicity risk. 2
• No dose adjustment needed for renal impairment; safety of multiple doses in severe liver disease is uncertain. 1, 2
• Ivermectin is probably compatible with pregnancy and breastfeeding based on available human data. 2

Alternative Topical Agents

Benzyl Benzoate 25%

• Benzyl benzoate 25% applied daily for three consecutive days achieved an 87% cure rate in a 2024 head-to-head trial, making it an appropriate first-line alternative when permethrin resistance is suspected. 3
• Expect a burning sensation in approximately 43% of patients, but tolerability is generally reasonable. 3

Lindane 1% (Last Resort Only)

• Use lindane only if the patient cannot tolerate or has failed recommended therapies; it is a last-resort agent due to neurotoxicity risk. 1, 2
• Never use lindane in children younger than 10 years, pregnant or lactating women, or patients with extensive dermatitis. 1, 2
• Apply a thin layer from the neck down and wash off after 8 hours; do not apply immediately after bathing to avoid seizures. 1, 2
• Lindane is associated with neural tube defects, aplastic anemia, and documented resistance in some geographic areas. 1

Essential Adjunctive Measures

Environmental Decontamination

• Machine-wash and machine-dry all bedding and clothing on hot cycles, or dry-clean them; this is mandatory to prevent reinfestation. 1, 2
• If laundering is not feasible, isolate items from body contact for at least 72 hours. 1, 2
• Fumigation of living areas is unnecessary. 1, 2

Contact Management

• Examine and treat all household members and close contacts from the preceding month simultaneously, even if asymptomatic, to eliminate reservoirs of infestation. 1, 2
• Avoid sexual contact until both patients and partners have completed treatment and been reassessed. 1, 2

Post-Treatment Expectations

Normal Post-Scabetic Symptoms

• Pruritus may persist for up to 2 weeks after successful therapy due to allergic dermatitis; this does not indicate treatment failure. 1, 2
• Use topical corticosteroids (class I–II) twice daily on persistent nodular lesions and add oral antihistamines for symptomatic relief. 2
• Retreatment is warranted only if live mites are observed on microscopy or dermoscopy after 2 weeks, or if symptoms continue beyond this period. 2

Common Pitfall

• Premature retreatment for lingering itching is a frequent error that leads to unnecessary medication exposure, toxicity risk, and increased costs without clinical benefit. 2

Crusted (Norwegian) Scabies

• Combination therapy is required: permethrin 5% cream applied daily for 7 days then twice weekly, plus oral ivermectin 200 µg/kg on days 1,2,8,9, and 15. 1, 2
• Additional ivermectin doses on days 22 and 29 may be needed for severe disease. 1, 2
• Patient isolation and simultaneous treatment of all contacts are mandatory because crusted scabies is highly contagious. 1, 2
• Avoid lindane due to neurotoxicity risk with heavy applications on denuded skin. 1

Special Populations

Immunocompromised/HIV-Positive Patients

• Treat uncomplicated scabies with the same regimens as immunocompetent individuals. 2
• These patients have higher risk of developing crusted scabies and may require more aggressive combination therapy. 1, 2

Pregnancy and Lactation

• Permethrin is the safest option during pregnancy and breastfeeding. 2
• Ivermectin shows low risk in human pregnancy data and is probably compatible with lactation. 2
• Never use lindane due to association with neural tube defects. 2

Treatment Failure Evaluation

If symptoms persist beyond 2 weeks, consider these causes before retreating: 1, 4

• Improper application of topical agents 4
• Failure to repeat ivermectin on day 14 4
• Incomplete environmental decontamination 4
• Untreated household contacts 4
• Absence of written treatment instructions 4
• True medication resistance (increasingly documented for permethrin) 3, 4